NVA-011

N/A

Report date: 2025/05/15 17:56:22

NME

Base Information

Drug NameNVA-011

Drug Alias NameNVA-011

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor antagonists

TargetsGlutamate [NMDA] receptor

Therapy Area/IndicationsCraniocerebral Trauma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNeureva

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNeureva

Active IndicationsN/A

Inactive IndicationsCraniocerebral Trauma

ATC CodeN/A